COVID-19 vaccination for patients with epilepsy: A Chinese expert consensus.
- 2023-10
- Epilepsy & behavior : E&B 147
- Xuewu Liu
- Qun Wang
- Liankun Ren
- Xiqin Fang
- Zhiyi He
- Jing Ding
- Kang Wang
- Huiqin Xu
- Hua Zhang
- Yijun Song
- Qiang Lu
- Meizhen Sun
- Xiong Han
- Lili Cao
- Weihong Lin
- Xiaoyi Li
- Qing Zhang
- Yao Ding
- Furong Wang
- Tiancheng Wang
- Jiwen Wang
- Xiaorong Liu
- Yuan Wu
- Yangmei Chen
- Zhanhui Feng
- Shoulei Wang
- Xiangqing Wang
- Yuguang Guan
- Xufang Xie
- Huapin Huang
- Ming Zhang
- Xiaoshan Wang
- Zhen Hong
- Wen Jiang
- Yanbing Han
- Yulei Deng
- Jiangming Zhao
- Jianxiang Liao
- Yu Wang
- Yajun Lian
- PubMed: 37625346
- DOI: 10.1016/j.yebeh.2023.109387
Study Design
- Type
- Review
Coronavirus disease-2019 (COVID-19) first emerged in late 2019 and has since spread worldwide. More than 600 million people have been diagnosed with COVID-19, and over 6 million have died. Vaccination against COVID-19 is one of the best ways to protect humans. Epilepsy is a common disease, and there are approximately 10 million patients with epilepsy (PWE) in China. However, China has listed "uncontrolled epilepsy" as a contraindication for COVID-19 vaccination, which makes many PWE reluctant to get COVID-19 vaccination, greatly affecting the health of these patients in the COVID-19 epidemic. However, recent clinical practice has shown that although a small percentage of PWE may experience an increased frequency of seizures after COVID-19 vaccination, the benefits of COVID-19 vaccination for PWE far outweigh the risks, suggesting that COVID-19 vaccination is safe and recommended for PWE. Nonetheless, vaccination strategies vary for different PWE, and this consensus provides specific recommendations for PWE to be vaccinated against COVID-19.